De Giorgio M, Fagiuoli S
Dipartimento Medicina Specialistica e dei Trapianti, U.O. Gastroenterologia, Bergamo, Italy.
Dig Dis. 2007;25(3):279-81. doi: 10.1159/000103902.
The aim of this review was to assess the correct clinical management of hepatocellular carcinoma (HCC). Following the diagnosis, the correct choice of treatment must take into account both the anatomical/biological features of HCC and the functional status of the underlying cirrhosis. As of today, only the application of the BCLC scoring system, which stratifies patients according to HCC staging and degree of liver disease in a process leading to a specific treatment, has shown the best results in terms of survival.
本综述的目的是评估肝细胞癌（HCC）的正确临床管理。诊断后，治疗的正确选择必须同时考虑HCC的解剖学/生物学特征以及潜在肝硬化的功能状态。截至目前，只有应用BCLC评分系统，根据HCC分期和肝病程度对患者进行分层，进而得出特定的治疗方案，在生存率方面显示出了最佳效果。
